General Information
Version
8.5
Revision date
2023-07-01
Product name
CFBE41o- Human CF Bronchial Epithelial Cell Line
1.2.1 Relevant identified uses
Research Use Only
Icons in SDS
Company Information
company name
Merck Pty Ltd
Section 2
SECTION 2: Hazards identification
2.2 Label elements
No hazard pictogram, no signal word, no hazard statement(s), no precautionary statement(s) required 2.3
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Although the cell lines are not known to contain any agents capable of harm humans the possibility of a contaminant, adventitious virus can rarely be excluded. Therefore, it is recommended that all animal / human cell lines are handled at Biosafety Level 2 containment [United States Government Publication "Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition" (CDC, 2009).] SECTION 3: Composition/information on ingredients
